NCALD and proximal spinal muscular atrophy: Moreover, these results are in line with our findings on the improvement of NMJ innervation upon Ncald-ASO treatment in SMA mice, highlighting the potential of NCALD reduction as a promising therapeutic approach that targets one of the key pathological features in SMA, the NMJ.